NURIX THERAPEUTICS, INC. (NRIX) Operating cash flow 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$249.5MFY2025 · since FY2019: $601,000 → -$249.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$249.5M | -44.5% |
| FY2024 | -$172.6M | -112.1% |
| FY2023 | -$81.4M | +49.1% |
| FY2022 | -$159.8M | -89.4% |
| FY2021 | -$84.4M | -105356.3% |
| FY2020 | -$80,000 | -113.3% |
| FY2019 | $601,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice